Johnson & Johnson (JNJ)  announced record sales of $16.0 billion for the fourth quarter of 2007, an increase of 16.6% as compared to the fourth quarter of 2006.

Net earnings and diluted earnings per share for the fourth quarter of 2007 were $2.4 billion and $.82 respectively, representing increases of 9.5% and 10.8% respectively, compared to the same period in 2006

While most shares are off 5% before the open, JNJ is only off 1.5%

Douglas A. McIntyre